FIA
PROK icon

FNY Investment Advisers’s ProKidney PROK Stock Holding History

FNY Investment Advisers’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
21,000
+20,000
+2,000% +$36.6K 0.02% 442
2026
Q1 		$1K Sell
1,000
-58,052
-98% -$123K ﹤0.01% 720
2025
Q4 		$132K Buy
+59,052
New +$155K 0.04% 306
2022
Q1 		– Sell
-41,328
Closed -$409K – 873
2021
Q4 		$409K Sell
41,328
-74,672
-64% -$738K 0.22% 107
2021
Q3 		$1.14M Buy
+116,000
New +$1.14M 0.53% 50

Other funds holding PROK

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

FNY Investment Advisers's PROK Position: Q2 2026 in Review

FNY Investment Advisers increased its ProKidney (PROK) stake by 2,000% in Q2 2026, buying an estimated $36.6K and bringing the position to 21,000 shares worth $42K. The position accounts for 0.02% of the portfolio, ranked #442.

FNY Investment Advisers first reported a position in PROK in Q3 2021 and has held it in 5 quarters since. The position peaked at $1.14M in Q3 2021. 7 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • FNY Investment Advisers held 21,000 shares of ProKidney worth $42K as of Q2 2026.
  • FNY Investment Advisers bought 20,000 ProKidney shares in Q2 2026, an estimated $36.6K.
  • ProKidney made up 0.02% of FNY Investment Advisers's portfolio in Q2 2026, its #442 holding.
  • FNY Investment Advisers first reported a position in ProKidney in Q3 2021 and has held it in 5 quarters since.
  • FNY Investment Advisers's ProKidney position peaked at $1.14M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.